Background pattern
Agomelatina stada 25 mg comprimidos recubiertos con pelicula efg

Agomelatina stada 25 mg comprimidos recubiertos con pelicula efg

About the medicine

How to use Agomelatina stada 25 mg comprimidos recubiertos con pelicula efg

Introduction

Prospect: information for the patient

Agomelatina Stada 25 mg film-coated tablets EFG

Read this prospect carefully before starting to take this medicine, as it contains important information for you.

-Keep this prospect, as you may need to read it again.

-If you have any doubts, consult your doctor or pharmacist.

-This medicine has been prescribed only to you and should not be given to others, even if they have the same symptoms as you, as it may harm them.

-If you experience any adverse effects, consult your doctor or pharmacist even if they do not appear in this prospect. See section 4.

1.What is Agomelatina Stada and for what it is used

2.What you need to know before starting to take Agomelatina Stada

3.How to take Agomelatina Stada

4.Possible adverse effects

5Storage of Agomelatina Stada

6.Contents of the package and additional information

1. What is Agomelatina and what is it used for

This medicationcontains the active ingredient agomelatina. Agomelatina belongs to a group of medications called antidepressants and has been prescribed to treat your depression.

Agomelatinais used in adults.

Depression is a continued alteration of mood that interferes with daily life. The symptoms of depression vary from person to person, but usually consist of a deep sadness, feelings of uselessness, loss of interest in hobbies, sleep disturbances, feeling of slowness, feeling of anxiety, and weight changes.

The expected benefits ofagomelatinaare to gradually reduce and eliminate the symptoms related to your depression.

2. What you need to know before starting to take Agomelatina Stada

Do not take agomelatine

-if you are allergic to agomelatine or any of the other ingredients of this medicine (listed in section 6).

-if your liver does not function properly (liver insufficiency).

-if you are taking fluvoxamine (another medicine used in the treatment of depression) or ciprofloxacin (an antibiotic).

Warnings and precautions

There may be reasons why agomelatine is not suitable for you:

-If you are taking medicines that are known to affect the liver. Ask your doctor about these medicines.

-If you have obesity or overweight, ask your doctor.

-If you are diabetic, ask your doctor.

-If you have elevated liver enzyme levels before treatment, your doctor will decide if this medicine is suitable for you.

-If you have bipolar disorder, have experienced or develop manic symptoms (a period of excessive excitement and abnormal elevation of emotions), inform your doctor before starting to take this medicine or before continuing to take it (see also “Possible side effects” in section 4).

-If you have dementia, your doctor will perform an individual assessment to decide if it is appropriate for you to take agomelatine.

During your treatment with agomelatine:

What to do to avoid potentially serious liver problems:

- Your doctor must check that your liver is functioning correctlybefore starting treatment.Some patients may experience increases in blood levels of liver enzymes during treatment with this medicine. Therefore, follow-up analyses should be performed with the following frequency:

Before starting or increasing the dose

Approximately at 3 weeks

Approximately at 6 weeks

Approximately at 12 weeks

Approximately at 24 weeks

Blood analysis

?

?

?

?

?

Based on the evaluation of these analyses, your doctor will decide if you should receive or continue to use this medicine (see also section 3 “How to take agomelatine”).

Be aware of the signs and symptoms that may indicate that your liver is not functioning properly.

-If you noticeany of these signs and symptoms of liver problems:unusual darkening of urine, pale stools, yellowing of the skin/eyes, upper right abdominal pain, unusual fatigue (especially associated with other previously mentioned symptoms), seek urgent advice from a doctor, who may recommend stopping treatment with agomelatine.

The effect of agomelatine has not been documented in patients over 75 years. Agomelatine should therefore not be used in these patients.

Thoughts of suicide and worsening of depression

If you are depressed, you may occasionally have thoughts of self-harm or suicide. These thoughts may be increased at the beginning of treatment with antidepressants, as all these medicines take time to exert their effect, usually two weeks but sometimes longer.

It is more likely that you will have these thoughts:

-if you have previously had thoughts of self-harm or suicide.

-if you are a young adult. There is information from clinical trials that has shown an increased risk of suicidal behavior in young adults (under 25 years) who have a psychiatric disorder and are being treated with antidepressants.

Contact your doctor or go directly to the hospital as soon as you have any thoughts of self-harm or suicide.

It may be helpful to tell a close relative or friend that you are depressed and ask them to read this leaflet. You may ask them to tell you if they notice that your depression is worsening, or if they are concerned about changes in your behavior.

Children and adolescents

This medicine is not intended for use in children and adolescents (under 18 years).

Use of agomelatine with other medicines

Inform your doctor or pharmacist if you are using or have recently used or may need to take any other medicine.

You should not take agomelatine with certain medicines (see also “Do not take agomelatine” in section 2): fluvoxamine (another medicine used in the treatment of depression) and ciprofloxacin (an antibiotic) as they may modify the planned dose of agomelatine in your blood.

Make sure to inform your doctor if you are taking any of the following medicines: propranolol (a beta-blocker used in the treatment of hypertension), enoxacine (an antibiotic) and if you smoke more than 15 cigarettes per day.

Agomelatine and alcohol

It is not recommended to drink alcohol while being treated with this medicine.

Pregnancy

If you are pregnant or breastfeeding, consult your doctor or pharmacist before using this medicine.

Breastfeeding

Consult your doctor if you are breastfeeding your child or intend to do so, as you should stop breastfeeding if you take agomelatine.

Consult your doctor or pharmacist before using any medicine.

Driving and operating machinery

You may feel dizziness or drowsiness that may affect your ability to drive or operate machinery. Make sure you are sure of your reaction before driving or operating machinery.

Agomelatine Stada contains sodium

This medicine contains less than 1 mmol of sodium (23 mg) per tablet; this is, essentially “sodium-free”.

3. How to take/use Agomelatine

Follow exactly the administration instructions of this medication indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.

The recommended dose ofagomelatineis one tablet (25 mg) before bedtime. In some cases, your doctor may prescribe a higher dose (50 mg), that is, two tablets to be taken together before bedtime.

In most people with depressionagomelatinestarts to act on the symptoms of depression within a period of two weeks from the start of treatment. Your doctor may continue prescribing this medication when you feel better to prevent depression from coming back.

Your depression should be treated for a sufficient period of at least 6 months to ensure that you no longer have symptoms.

Do not stop taking your medication without consulting your doctor even if you feel better.

This medicationis for oral administration. You should swallow your tablet with the help of a glass of water. You can takeagomelatinewith or without food.

How to switch from an antidepressant (SSRI / SNRI) toagomelatine?

If your doctor changes your previous antidepressant medication from an SSRI or SNRI toagomelatine, they will inform you about how to discontinue treatment with your previous medication when you start takingagomelatine.

You may experience withdrawal symptoms related to the interruption of previous treatment for several weeks, even if the dose of your previous antidepressant medication is gradually reduced.

Withdrawal symptoms include: dizziness, numbness, sleep disturbance, agitation or anxiety, headache, nausea, vomiting, and tremors. These effects are generally mild to moderate and disappear spontaneously within a few days.

If treatment withagomelatinebegins while the dose of the previous medication is gradually reduced, possible withdrawal symptoms should not be confused with a lack of effect ofagomelatineat the beginning of treatment.

You should consult your doctor about the best way to discontinue your previous antidepressant treatment when you start treatment withagomelatine.

Liver function monitoring (see also section 2):

Your doctor will ask for tests to check that your liver is functioning properly before starting treatment and, subsequently, periodically during treatment, normally after 3 weeks, 6 weeks, 12 weeks, and 24 weeks. If your doctor increases the dose to 50 mg, tests should be performed at the time of dose increase and, subsequently, periodically during treatment, normally after 3 weeks, 6 weeks, 12 weeks, and 24 weeks. Subsequently, tests will be performed if the doctor considers it necessary.

You should not use this medicationif your liver is not functioning properly.

If you have kidney problems, your doctor will perform an individual evaluation to decide if it is safe for you to take this medication.

If you take moreagomelatinethan you should

In case of overdose or accidental ingestion, consult your doctor, pharmacist, or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

The experience of overdose withagomelatineis limited, but the symptoms reported include upper stomach pain, drowsiness, fatigue, agitation, anxiety, tension, dizziness, cyanosis, or general discomfort.

If you forgot to take agomelatine

Do not take a double dose to compensate for the missed doses. Simply take the next dose at the usual time.

The printed calendar in the blister pack containing the tablets will help you remember when you last took a tablet ofagomelatine.

If you interrupt treatment withagomelatine

You should ask your doctor before interrupting treatment with this medication.

If you think the effect ofagomelatineis too strong or too weak, consult your doctor or pharmacist.

If you have any other doubts about the use of this medication, ask your doctor or pharmacist.

4. Possible Adverse Effects

Like all medications, this medication may produce adverse effects, although not everyone will experience them.

The majority of adverse effects are mild or moderate. They usually appear in the first two weeks of treatment and are normally transient.

These adverse effects include:

-Very Common Adverse Effects(may affect more than 1 in 10 people): headache.

-Common Adverse Effects(may affect up to 1 in 10 people): dizziness, drowsiness, insomnia (difficulty sleeping), nausea, diarrhea, constipation, abdominal pain, back pain, fatigue, anxiety, abnormal dreams, elevated liver enzyme levels in the blood, vomiting, weight gain.

-Uncommon Adverse Effects(may affect up to 1 in 100 people): migraine, paresthesia (tingling in the fingers and toes), blurred vision, restless leg syndrome (a disorder characterized by an irresistible urge to move the legs), tinnitus (ringing in the ears), excessive sweating (hyperhidrosis), eczema, pruritus, urticaria (hives), agitation, irritability, restlessness, aggressive behavior, nightmares, mania/hypomania (see also "Warnings and Precautions" in section 2), suicidal thoughts or behavior, confusion, weight loss.

-Rare Adverse Effects(may affect up to 1 in 1,000 people): severe skin rash (erythematous rash), facial edema (swelling) and angioedema (swelling of the face, lips, tongue, and/or throat that may cause difficulty breathing or swallowing), hepatitis, jaundice (yellowing of the skin or eyes), liver failure*, hallucinations, inability to remain still (due to physical and mental restlessness), inability to completely empty the bladder.

* A reduced number of cases led to liver transplant or death.

Reporting Adverse Effects

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect not listed in this prospectus. You can also report them directly through the national notification system: Spanish System for Pharmacovigilance of Medicinal Products for Human Use:https:// www.notificaRAM.es.By reporting adverse effects, you can contribute to providing more information on the safety of this medication.

5. Conservation of Agomelatina Stada

Keep this medication out of the sight and reach of children.

Do not use this medication after the expiration date that appears on the packaging and blister, after CAD. The expiration date is the last day of the month indicated.

Store in the original packaging to protect it from moisture. This medication does not require special storage conditions.

Medications should not be disposed of through drains or trash. Deposit the packaging and medications you no longer need at the SIGRE point of the pharmacy. Ask your pharmacist how to dispose of the packaging and medications you no longer need. In this way, you will help protect the environment.

6. Content of the container and additional information

Composition of Agomelatina Stada

  • The active ingredient is agomelatine. Each film-coated tablet contains co-crystals of agomelatine-citric acid equivalent to 25 mg of agomelatine.
  • The other components present in the core are colloidal silicon dioxide, microcrystalline cellulose, mannitol, povidone, anhydrous colloidal silica, crospovidone, sodium fumarate ester, magnesium stearate, and stearic acid.
  • The coating components are hypromellose, macrogol, titanium dioxide (E171), talc, and yellow iron oxide (E172).

Appearance of Agomelatina Stada and content of the container

Agomelatina Stada 25 mg film-coated tablets are yellow, oblong, biconvex, measuring 9 mm x 4.5 mm.

Agomelatina Stada 25 mg film-coated tablets are available in blisters. The containers contain 7, 14, 28, 42, 56, 84, 98, or 100 (clinical pack) tablets or 7x1, 14x1, 28x1, 42x1, 56x1, 84x1, 98x1, 100 (clinical pack) x1 tablets (single dose).

Only some container sizes may be commercially marketed.

Holder of the marketing authorization and responsible for manufacturing

Holder of the Marketing Authorization

Laboratorio STADA, S.L.

Frederic Mompou, 5

08960 Sant Just Desvern (Barcelona)

Spain

[email protected]

Responsible for manufacturing

MEDIS International a.s., výrobní závod Bolatice

Prumyslova 961/16

747 23 Bolatice

Republic of Czech

or

STADA Arzneimittel AG

Stadastrasse 2 – 18

61118 Bad Vilbel

Germany

Last review date of this leaflet:July 2018

The detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es/.

About the medicine

How much does Agomelatina stada 25 mg comprimidos recubiertos con pelicula efg cost in Spain ( 2025)?

The average price of Agomelatina stada 25 mg comprimidos recubiertos con pelicula efg in August, 2025 is around 30.66 EUR. Prices may vary depending on the region, pharmacy, and whether a prescription is required. Always check with a local pharmacy or online source for the most accurate information.

Talk to a doctor online

Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.

5.0(17)
Doctor

Ekaterina Agapova

Neurology8 years of experience

Dr. Ekaterina Agapova is a neurologist specialising in the diagnosis and treatment of neurological conditions and chronic pain. She provides online consultations for adults, combining evidence-based medicine with a personalised approach.

She offers expert care for:

  • Headaches and migraines, including tension-type and cluster headaches.
  • Neck and back pain, both acute and chronic.
  • Chronic pain syndromes – fibromyalgia, neuropathic pain, post-traumatic pain.
  • Mononeuropathies – carpal tunnel syndrome, trigeminal neuralgia, facial nerve palsy.
  • Polyneuropathies – diabetic, toxic, and other types.
  • Multiple sclerosis – diagnosis, monitoring, long-term support.
  • Dizziness and coordination disorders.
  • Sleep disturbances – insomnia, daytime sleepiness, fragmented sleep.
  • Anxiety, depression, and stress-related conditions.

Dr. Agapova helps patients manage complex neurological symptoms like pain, numbness, weakness, poor sleep, and emotional distress. Her consultations focus on accurate diagnosis, clear explanation of findings, and tailored treatment plans.

If you’re struggling with chronic pain, migraines, nerve disorders, or sleep problems, Dr. Agapova offers professional guidance to restore your well-being.

CameraBook a video appointment
More times
5.0(35)
Doctor

Yevgen Yakovenko

General surgery11 years of experience

Dr. Yevgen Yakovenko is a licensed surgeon and general practitioner in Spain and Germany. He specialises in general, paediatric, and oncological surgery, internal medicine, and pain management. He offers online consultations for adults and children, combining surgical precision with therapeutic support. Dr Yakovenko works with patients across different countries and provides care in Ukrainian, Russian, English, and Spanish.

Areas of medical expertise:

  • Acute and chronic pain: headaches, muscle and joint pain, back pain, abdominal pain, postoperative pain. Identifying the cause, selecting treatment, and creating a care plan.
  • Internal medicine: heart, lungs, gastrointestinal tract, urinary system. Management of chronic conditions, symptom control, second opinions.
  • Pre- and postoperative care: risk assessment, decision-making support, follow-up after surgery, rehabilitation strategies.
  • General and paediatric surgery: hernias, appendicitis, congenital conditions, both planned and urgent surgeries.
  • Injuries and trauma: bruises, fractures, sprains, soft tissue damage, wound care, dressing, referral when in-person care is required.
  • Oncological surgery: diagnosis review, treatment planning, and long-term follow-up.
  • Obesity treatment and weight management: a medical approach to weight loss, including assessment of underlying causes, evaluation of comorbidities, development of a personalised plan (nutrition, physical activity, pharmacotherapy if needed), and ongoing progress monitoring.
  • Imaging interpretation: analysis of ultrasound, CT, MRI, and X-ray results, surgical planning based on imaging data.
  • Second opinions and medical navigation: clarifying diagnoses, reviewing current treatment plans, helping patients choose the best course of action.

Experience and qualifications:

  • 12+ years of clinical experience in university hospitals in Germany and Spain.
  • International education: Ukraine – Germany – Spain.
  • Member of the German Society of Surgeons (BDC).
  • Certified in radiological diagnostics and robotic surgery.
  • Active participant in international medical conferences and research.

Dr Yakovenko explains complex topics in a clear, accessible way. He works collaboratively with patients to analyse health issues and make evidence-based decisions. His approach is grounded in clinical excellence, scientific accuracy, and respect for each individual.

If you are unsure about a diagnosis, preparing for surgery, or want to discuss your test results – Dr Yakovenko will help you evaluate your options and move forward with confidence.

CameraBook a video appointment
More times
5.0(5)
Doctor

Jonathan Marshall Ben Ami

Family medicine8 years of experience

Dr. Jonathan Marshall Ben Ami is a licensed family medicine doctor in Spain. He provides comprehensive care for adults and children, combining general medicine with emergency care expertise to address both acute and chronic health concerns.

Dr. Ben Ami offers expert diagnosis, treatment, and follow-up for:

  • Respiratory infections (cold, flu, bronchitis, pneumonia).
  • ENT conditions such as sinusitis, ear infections, and tonsillitis.
  • Digestive issues including gastritis, acid reflux, and irritable bowel syndrome (IBS).
  • Urinary tract infections and other common infections.
  • Management of chronic diseases: high blood pressure, diabetes, thyroid disorders.
  • Acute conditions requiring urgent medical attention.
  • Headaches, migraines, and minor injuries.
  • Wound care, health check-ups, and ongoing prescriptions.

With a patient-focused and evidence-based approach, Dr. Ben Ami supports individuals at all stages of life — offering clear medical guidance, timely interventions, and continuity of care.

CameraBook a video appointment
More times
5.0(4)
Doctor

Salome Akhvlediani

Pediatrics11 years of experience

Dr Salome Akhvlediani is a paediatrician providing online consultations for children of all ages. She supports families with preventive care, diagnosis, and long-term management of both acute and chronic conditions.

Her areas of focus include:

  • Fever, infections, cough, sore throat, and digestive issues.
  • Preventive care – vaccinations, regular check-ups, and health monitoring.
  • Allergies, asthma, and skin conditions.
  • Nutritional advice and healthy development support.
  • Sleep difficulties, fatigue, and behavioural concerns.
  • Ongoing care for chronic or complex health conditions.
  • Guidance for parents and follow-up after medical treatment.

Dr Akhvlediani combines professional care with a warm, attentive approach – helping children stay healthy and supporting parents at every stage of their child’s growth.

CameraBook a video appointment
More times
View all doctors

Get updates and exclusive offers

Be the first to know about new services, platform updates, and subscriber-only promos.

Subscribe
Follow us on social media
FacebookInstagram